Correlation Between Regeneron Pharmaceuticals and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Nuvalent.
Diversification Opportunities for Regeneron Pharmaceuticals and Nuvalent
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Regeneron and Nuvalent is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Nuvalent go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Nuvalent
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.75 times more return on investment than Nuvalent. However, Regeneron Pharmaceuticals is 1.34 times less risky than Nuvalent. It trades about -0.08 of its potential returns per unit of risk. Nuvalent is currently generating about -0.09 per unit of risk. If you would invest 74,460 in Regeneron Pharmaceuticals on November 19, 2024 and sell it today you would lose (7,100) from holding Regeneron Pharmaceuticals or give up 9.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. Nuvalent
Performance |
Timeline |
Regeneron Pharmaceuticals |
Nuvalent |
Regeneron Pharmaceuticals and Nuvalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and Nuvalent
The main advantage of trading using opposite Regeneron Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |